BioSpace News Archive

Policy

We May Be Done with COVID-19, But it May Not Be Done with Us

Public health officials are seeing a notable rise in cases and expressing concerns over more subvariants of the SARS-CoV-2 virus. For those stories and more, continue reading.

May 2, 2022
·
6 min read
·
Mark Terry
Business

Patient Square Kickstarts Biotech Investment Firm Enavate Sciences

Enavate Sciences launched with an initial capital investment of $300 million from health care investment firm Patient Square Capital. Enavate is a new biotech investment firm.

May 2, 2022
·
3 min read
·
Mark Terry
Business

Pfizer Vaccines Head Kathrin Jansen Stepping Down after Long, Illustrious Career

Pfizer vaccine head Kathrin Jansen is stepping down from the pharma giant after spearheading the development of the COVID-19 vaccine Comirnaty.

May 2, 2022
·
3 min read
·
Alex Keown
Business

Gilead Snaps Up Rights to Promising Dragonfly NK Engager Program

Gilead and Dragonfly announced their collaboration today, with an end goal of bringing the DF7001 NK engager program designed for patients with cancer or inflammatory diseases.

May 2, 2022
·
2 min read
·
Jazmine Colatriano
Drug Development

Positive Blepharitis Data in Hand, Tarsus Gears Up for FDA Submission (Updated)

Tarsus announced positive topline data from its Phase III clinical trial of TP-03 Demodex blepharitis, along with the commencement of an underwritten public offering of $50 million of shares of its common stock.

May 2, 2022
·
2 min read
·
Hayley Shasteen
Deals

Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms

Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it has completed the acquisition of GeneDx, LLC (“GeneDx”), a leader in genomic testing and analysis for rare disorders, from OPKO Health, Inc. (Nasdaq: OPK) (“OPKO”).

May 2, 2022
·
6 min read
Business

Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results

Ocugen, Inc. today announced that it will host a conference call to provide a business update and discuss its first quarter 2022 financial results at 8:30 a.m. ET on Friday, May 6, 2022.

May 2, 2022
·
2 min read
Business

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2022 Financial Results on May 9

Avadel Pharmaceuticals plc announced that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 9, 2022, to provide a corporate update and discuss the Company’s financial results for the first quarter ended March 31, 2022.

May 2, 2022
·
1 min read
Business

aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results

aTyr Pharma, Inc. announced that it will report first quarter 2022 financial results and provide a corporate update after the market close on Monday, May 9, 2022.

May 2, 2022
·
1 min read
Business

Fulcrum Therapeutics to Host First Quarter 2022 Financial Results Conference Call and Webcast on Monday, May 9, 2022 at 8:00 a.m. ET

Fulcrum Therapeutics, Inc.®, a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that its first quarter 2022 financial results will be released on Monday, May 9, 2022 before the U.S. financial markets open.

May 2, 2022
·
1 min read